Press release
Growing cancer burden and pressure for earlier detection accelerate adoption of artificial intelligence across oncology diagnosis and treatment pathways
Artificial Intelligence in Cancer Diagnosis and Therapy Market
GET EXCLUSIVE SAMPLE COPY OF THIS REPORT HERE @ https://www.emergenresearch.com/request-sample/1106
KEY GROWTH DRIVERS
Healthcare systems are increasing investments in artificial intelligence technologies to improve efficiency across cancer screening, diagnosis, treatment planning, and patient monitoring. The growing volume of imaging data generated through radiology, pathology, and genomics platforms is encouraging the use of AI-powered analytical tools. Regulatory agencies are also providing pathways for the approval and deployment of software-based medical devices, supporting market adoption. Pharmaceutical companies and healthcare providers are increasingly utilizing AI to identify treatment responses and optimize oncology drug development programs. For instance, in January 2024, Siemens Healthineers, Germany, expanded its AI-enabled oncology imaging portfolio to support clinical decision-making and workflow efficiency across healthcare facilities. These are some of the key factors driving revenue growth of the Artificial Intelligence in Cancer Diagnosis and Therapy Market.
MARKET RESTRAINTS
However, high implementation costs associated with AI platforms and advanced healthcare IT infrastructure remain a challenge for many healthcare providers. Data privacy requirements and regulatory compliance obligations can increase deployment complexity, particularly when handling sensitive patient information. Limited availability of standardized clinical datasets and concerns regarding algorithm transparency may also affect adoption across certain healthcare settings. Integration challenges with existing hospital information systems can further delay implementation. These factors are expected to limit Artificial Intelligence in Cancer Diagnosis and Therapy Market growth to some extent over the forecast period.
Get Access to Full summary of the Market report @ https://www.emergenresearch.com/industry-report/artificial-intelligence-in-cancer-diagnosis-and-therapy-market
SEGMENT HIGHLIGHTS
The diagnosis segment accounted for the largest share of the market in 2025. AI technologies are increasingly used in radiology, pathology, mammography, and other imaging applications to assist clinicians in identifying cancer at earlier stages. Growing adoption of computer-aided detection systems and digital pathology platforms continues to support demand within this segment.
The therapy segment is expected to register the fastest growth during the forecast period. Healthcare providers are increasingly using AI to support treatment planning, precision oncology, drug response prediction, and patient monitoring. Expanding use of genomic data and personalized medicine approaches is contributing to growth in this segment.
REGIONAL OUTLOOK
North America accounted for the largest share of the Artificial Intelligence in Cancer Diagnosis and Therapy Market in 2025. The region benefits from advanced healthcare infrastructure, widespread adoption of digital health technologies, and substantial investments in oncology research. The U.S. National Cancer Institute continues to support cancer research programs involving artificial intelligence and advanced data analytics. Companies such as GE HealthCare, IBM, and Microsoft maintain active investments in AI-enabled healthcare solutions across the region.
Europe represented a substantial share of the market due to growing investments in digital healthcare systems and cancer research initiatives. The European Commission's Europe Beating Cancer Plan continues to encourage the adoption of technologies that support earlier diagnosis and improved treatment outcomes. Healthcare providers across Germany, France, and the United Kingdom are increasing deployment of AI-enabled diagnostic tools. Companies including Siemens Healthineers are contributing to regional market development through continued product innovation and healthcare partnerships.
Asia Pacific is expected to register the fastest revenue growth during the forecast period. Rising cancer prevalence, increasing healthcare expenditure, and expanding adoption of digital health technologies are driving market expansion across China, India, Japan, and South Korea. Governments in the region are investing in artificial intelligence development and healthcare modernization programs. Growing deployment of advanced diagnostic imaging systems and increasing availability of healthcare data are expected to support adoption of AI-based oncology solutions throughout the forecast period.
Interested in purchasing this Report? Click here @ https://www.emergenresearch.com/select-license/1106
Artificial Intelligence in Cancer Diagnosis and Therapy Market Segmentation Analysis :
By Component Outlook (Revenue, USD Billion; 2024-2035)
Software
Hardware
Services
By Technology Outlook (Revenue, USD Billion; 2024-2035)
Machine Learning
Deep Learning
Natural Language Processing (NLP)
Computer Vision
By Application Outlook (Revenue, USD Billion; 2024-2035)
Cancer Diagnosis
Treatment Planning
Drug Discovery
Patient Monitoring
Others
By Cancer Type Outlook (Revenue, USD Billion; 2024-2035)
Lung Cancer
Breast Cancer
Prostate Cancer
Colorectal Cancer
Blood Cancer
Others
By End User Outlook (Revenue, USD Billion; 2024-2035)
Hospitals & Cancer Centers
Diagnostic Laboratories
Pharmaceutical & Biotech Companies
Research Institutes
Others
Regional Outlook (Revenue, USD Billion; 2024-2035)
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Contact us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: Emergen Research Insights | Navigating Industry Trends with Expert Analysis
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Growing cancer burden and pressure for earlier detection accelerate adoption of artificial intelligence across oncology diagnosis and treatment pathways here
News-ID: 4557943 • Views: …
More Releases from Emergen Research
Graph Database Market Size, Share & Trends | Global Industry Forecast to 2035
The global Graph Database market, valued at USD 5.37 Billion in 2025, is expected to reach USD 38.24 Billion by 2035, registering a revenue CAGR of 21.7% during the forecast period. Organizations are increasingly adopting graph database technologies to analyze highly connected data across financial services, healthcare, retail, telecommunications, manufacturing, and cybersecurity applications. Rising deployment of artificial intelligence, machine learning, and knowledge graph technologies is increasing demand for databases capable…
Energy-efficient building standards and infrastructure development increase dema …
The global Flat Glass market, valued at USD 112.40 Billion in 2025, is projected to reach USD 184.82 Billion by 2035, registering a revenue CAGR of 5.1% during the forecast period, according to the latest analysis by Emergen Research. Demand is increasing as governments and private developers invest in energy-efficient buildings, transportation infrastructure, and modern manufacturing facilities. Rising construction activity and expanding automotive production continue to support the use of…
Power grid reliability concerns and expanding critical infrastructure increase d …
The global Standby Generator Set market, valued at USD 25.23 Billion in 2025, is projected to reach USD 43.59 Billion by 2035, registering a revenue CAGR of 5.6% during the forecast period, according to the latest analysis by Emergen Research. Demand is increasing as businesses, healthcare facilities, data centers, and public infrastructure operators invest in reliable backup power systems to reduce operational disruptions during grid outages. Rising electricity demand, aging…
Procurement Outsourcing Market Size, Share & Trends | Global Industry Forecast t …
The global Procurement Outsourcing market, valued at USD 4.27 Billion in 2025, is expected to reach USD 15.40 Billion by 2035, registering a revenue CAGR of 13.8% during the forecast period. Organizations across manufacturing, healthcare, retail, financial services, and technology sectors are outsourcing procurement functions to improve operational efficiency and strengthen supplier management. Growing supply chain complexity, increasing procurement costs, and the need for greater spending transparency are encouraging enterprises…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
